FENCFENNEC PHARMACEUTICALS INC.

Nasdaq fennecpharma.com


$ 7.05 $ -0.08 (-1.12 %)    

Friday, 17-May-2024 15:59:51 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 7.04
$ 6.99
$ 0.00 x 0
$ 0.00 x 0
$ 6.71 - $ 7.06
$ 6.30 - $ 11.92
306,769
na
218.88M
$ 0.73
$ 76.96
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-28-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-29-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 03-28-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-15-2015 03-31-2015 10-Q
38 03-31-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 craig-hallum-maintains-buy-on-fennec-pharmaceuticals-lowers-price-target-to-17

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price targ...

 hc-wainwright--co-maintains-buy-on-fennec-pharmaceuticals-lowers-price-target-to-15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the ...

 fennec-pharmaceuticals-q1-2024-gaap-eps-041-beats-026-estimate-sales-25377m-beat-18876m-estimate

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate o...

 hc-wainwright--co-maintains-buy-on-fennec-pharmaceuticals-raises-price-target-to-18

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the ...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

 fennec-pharmaceuticals-q4-eps-010-misses-002-estimate-sales-973m-beat-867m-estimate

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate...

 craig-hallum-maintains-buy-on-fennec-pharmaceuticals-raises-price-target-to-18

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

 reported-sunday-fennec-pharmaceuticals-and-norgine-inked-an-exclusive-licensing-agreement-to-commercialize-pedmarqsi-in-europe-australia-and-new-zealand

Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI®, the first and only approve...

Core News & Articles

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company focused on improving th...

 earnings-scheduled-for-november-6-2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

 fennec-pharmaceuticals-q3-eps-007-beats-011-estimate-sales-651m-beat-542m-estimate

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate o...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

 hc-wainwright--co-maintains-buy-on-fennec-pharmaceuticals-lowers-price-target-to-17

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the ...

 earnings-scheduled-for-august-3-2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on reven...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION